Search hospitals > Alberta > EDMONTON
Cross Cancer Institute
Claim this profileEDMONTON, Alberta T6G 1Z2
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Non-Small Cell Lung Cancer
739 reported clinical trials
34 medical researchers
Summary
Cross Cancer Institute is a medical facility located in EDMONTON, Alberta. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer and other specialties. Cross Cancer Institute is involved with conducting 739 clinical trials across 386 conditions. There are 34 research doctors associated with this hospital, such as Quincy Chu, Michael Chu, MD, Michael Kolinsky, and John Walker, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
Quincy ChuCross Cancer Institute7 years of reported clinical research
Studies Tumors
Studies Cancer
17 reported clinical trials
48 drugs studied
Michael Chu, MDLondon Health Sciences Centre2 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Coronary Artery Disease
15 reported clinical trials
23 drugs studied
Michael KolinskyCross Cancer Institute3 years of reported clinical research
Studies Prostate Cancer
Studies Endometrial Cancer
6 reported clinical trials
20 drugs studied
John Walker, MDCross Cancer Institute7 years of reported clinical research
Studies Cancer
Studies Melanoma
5 reported clinical trials
12 drugs studied
Clinical Trials running at Cross Cancer Institute
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Tumors
Solid Tumors
Colorectal Cancer
Brain Tumor
Plasma Cell Neoplasms
Lymphoma
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of physician's choice (TPC) in participants with previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do not express programmed cell death ligand 1 (PD-L1) or in participants previously treated with anti-programmed cell death (ligand or protein) 1 (Anti-PD-(L)1) Agents in the early setting whose tumors do express PD-L1.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) and pembrolizumab versus treatment of physician's choice (TPC) and pembrolizumab in participants with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors express programmed cell death ligand 1 (PD-L1).
Recruiting4 awards Phase 3
ARV-471
for Breast Cancer
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer.
Recruiting2 awards Phase 35 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cross Cancer Institute?
Cross Cancer Institute is a medical facility located in EDMONTON, Alberta. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer and other specialties. Cross Cancer Institute is involved with conducting 739 clinical trials across 386 conditions. There are 34 research doctors associated with this hospital, such as Quincy Chu, Michael Chu, MD, Michael Kolinsky, and John Walker, MD.
Where is Cross Cancer Institute located?
The Cross Cancer Institute is situated at 11560 University Avenue NW, Edmonton, Alberta, T6G 1Z2. It is accessible by car, with real-time driving directions available to account for traffic and road conditions. For those preferring public transportation, bus and light rail stations are located at 117 Street & University Avenue and 114 Street & 83 Avenue.
Who should I call to ask about financial aid or insurance network?
**Cross Cancer Institute Financial Assistance and Insurance Information:**
- **Memorial Sloan Kettering Cancer Center:** For insurance inquiries, contact 646-497-9176, Monday through Friday.
- **Northwell Health:** Offers a financial assistance program for those uninsured or underinsured. Eligibility is based on family size and income, determined through an application process.
- **Roswell Park Comprehensive Cancer Center:** Provides financial assistance for New York State residents who are uninsured or struggling with out-of-pocket costs. Contact financial counselors at 716-845-4782.
- **NYU Langone Health:** Financial assistance available for patients without insurance or with partial insurance coverage. Apply through the financial assistance application and consult a financial counselor at any listed location.
What insurance does Cross Cancer Institute accept?
For information on insurance plans accepted by the Cross Cancer Institute in Alberta, Canada, please contact the institute directly.
What awards or recognition has Cross Cancer Institute received?
The Cross Cancer Institute, located in Edmonton, Alberta, is renowned for its comprehensive healthcare services for cancer patients. It has been awarded $5 million by the Alberta Cancer Foundation to fund innovative cancer research projects, underscoring its dedication to improving cancer care and treatment.